H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 10.5% of adults in Irving have diagnosed diabetes — 1.5 points below the U.S. 12% figure. Census population 256,684. Texas Medicare wound biologics: Novitas Solutions (JH). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Irving clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Irving storefront.
Skin Substitute Therapy Products in Irving, TX for clinics & physicians. Skin substitute therapy for compl… Compliance support & pricing — contact Hawk Medical.
CDC PLACES (2023, crude) estimates 10.5% of adults in Irving have diagnosed diabetes — 1.5 points below the U.S. 12% figure. Census city-proper population is 256,684. If you are adding skin substitute therapy, start with that epidemiology and with Novitas Solutions (JH) — not with a “near me” clinic listing. Hawk Medical ships nationwide; Joe Bradley’s own practice uses the same product classes.
National Skin Substitute Therapy Products notes (how the product actually works)CDC PLACES (2023, crude) estimates 10.5% of adults in Irving have diagnosed diabetes — 1.5 points below the U.S. 12% figure. Adult obesity in Irving is 31.6% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 15.8% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: JH / Novitas Solutions, sibling states AR, CO, LA, MS, NM, OK. Texas DSHS is the public-health home. We will not mash those grains into a fake “demand score.”
Vendor consolidation is boring on purpose: one account, IFUs filed, JH articles mapped. 20.6% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Pricing scripts have to match that mix. We will help write them. We will not book your patients.
CDC PLACES (2023, crude prevalence) estimates 10.5% of adults — 1.5 points below the U.S. 12% figure. Obesity is 31.6%; arthritis is 15.8%. That is place-level BRFSS modeling, not a clinic census and not a Irving trial.
Hawk Medical works with independent reps who already have physician call points. Territory conversations start at /become-a-rep — not by scraping this city URL.
It is the Census city-proper count — useful as scale for a city of 250k–500k. It is not a count of orthopedic groups, wound centers, or competitors. Underwrite the program against your referral sources, not against the skyline.
Texas is in CMS MAC JH, administered by Novitas Solutions. CTP and skin-substitute coverage is written at the MAC level. Confirm the current LCD/article before you set utilization — we help practices map product to those rules; we do not override them.
If you operate in Texas and another MAC state, say it on the first call. JH will not port 1:1. We would rather split utilization than watch a sister clinic copy Irving tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Irving, TX.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Irving is JH geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Irving — 1.5 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Texas Part B wound biologics follow this contractor (siblings: AR, CO, LA, MS, NM, OK). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Irving. Useful for joint-program math; still needs a diagnosis and privileging.
No Irving storefront. Joe Bradley is an active practice owner. skin substitute therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.